Invitae News

This is selected news for Invitae, which is filed under Sectors / Healthtech. There are 279 news items for this page. A press release filter page is also available for Invitae.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/6/2022 Commerce Bank Invests $30,000 in Invitae Co. (NYSE:NVTA) - Watch List News
Commerce Bank acquired a new position in Invitae Co. ( NYSE:NVTA ‚Ai Get Rating ) during the 2nd quarter, Holdings Channel reports. The firm acquired 12,548 shares of the medical research company's stock, valued at approximately $30,000. Several other institutional investors have also recently made changes to their positions in ...
watchlistnews.com
12/6/2022 Commerce Bank Invests $30,000 in Invitae Co. (NYSE:NVTA)
Commerce Bank bought a new position in Invitae Co. (NYSE:NVTA ‚Ai Get Rating) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,548 shares of the medical research company's stock, valued at approximately $30,000. Several other large investors ...
defenseworld.net
12/6/2022 Seaport Global Advisors LLC Purchases 27,122 Shares of Invitae Co. (NYSE:NVTA)
Seaport Global Advisors LLC boosted its position in Invitae Co. (NYSE:NVTA ‚Ai Get Rating) by 95.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 55,515 shares of the medical research company's stock after acquiring ...
modernreaders.com
12/4/2022 Quantbot Technologies LP Acquires 198,769 Shares of Invitae Co. (NYSE:NVTA)
Quantbot Technologies LP grew its holdings in Invitae Co. ( NYSE:NVTA ‚Ai Get Rating ) by 98.2% during the 2nd the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 401,216 shares of the medical research company's stock after purchasing an additional 198,769 shares during ...
Ticker Report
12/2/2022 Swiss National Bank Has $1.24 Million Stock Position in Invitae Co. (NYSE:NVTA)
Swiss National Bank boosted its holdings in shares of Invitae Co. (NYSE:NVTA ‚Ai Get Rating) by 5.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 506,600 shares of the medical research company's stock after buying an additional ...
defenseworld.net
12/2/2022 Swiss National Bank Buys 24,900 Shares of Invitae Co. (NYSE:NVTA)
Swiss National Bank lifted its stake in Invitae Co. (NYSE:NVTA ‚Ai Get Rating) by 5.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 506,600 shares of the medical research company's stock after purchasing an additional 24,900 shares ...
etfdailynews.com
12/2/2022 Nan Fung Group Holdings Ltd Cuts Stock Position in Invitae Co. (NYSE:NVTA)
Nan Fung Group Holdings Ltd lessened its stake in Invitae Co. (NYSE:NVTA ‚Ai Get Rating) by 92.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 11,337 shares of the medical research company's stock after selling 144,667 ...
dispatchtribunal.com
12/2/2022 Nan Fung Group Holdings Ltd Decreases Stake in Invitae Co. (NYSE:NVTA)
Nan Fung Group Holdings Ltd cut its holdings in Invitae Co. (NYSE:NVTA ‚Ai Get Rating) by 92.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,337 shares of the medical research ...
thelincolnianonline.com
12/1/2022 The "Paternity & Relationship Testing Services
... crosses the chasm into mainstream commerce. Companies Mentioned AlphaBiolabs Bureau Veritas Canadian DNA Services Easy DNA Eurofins Scientific Gene by Gene, Ltd. Genex Diagnostics Intelligenetics Invitae Corporation Laboratory Corporation of America Myriad Genetics/Myriad RBM Quest Diagnostics Verogen Key Topics Covered: 1 Market Guides 2 Introduction and Market Definition 3 ...
wapakdailynews.com
12/1/2022 Worldwide Paternity & Relationship Testing Services Industry to 2027: by Application and Product – ResearchAndMarkets.com
... crosses the chasm into mainstream commerce. Companies Mentioned - AlphaBiolabs - Bureau Veritas - Canadian DNA Services - Easy DNA - Eurofins Scientific - Gene by Gene, Ltd. - Genex Diagnostics - Intelligenetics - Invitae Corporation - Laboratory Corporation of America - Myriad Genetics/Myriad RBM - Quest Diagnostics - Verogen Key Topics Covered: 1 Market Guides 2 Introduction and Market Definition 3 ...
Business Wire
12/1/2022 Worldwide Paternity & Relationship Testing Services Industry to 2027: by Application and Product - ResearchAndMarkets.com
... crosses the chasm into mainstream commerce. Companies Mentioned - AlphaBiolabs - Bureau Veritas - Canadian DNA Services - Easy DNA - Eurofins Scientific - Gene by Gene, Ltd. - Genex Diagnostics - Intelligenetics - Invitae Corporation - Laboratory Corporation of America - Myriad Genetics/Myriad RBM - Quest Diagnostics - Verogen Key Topics Covered: 1 Market Guides 2 Introduction and Market Definition 3 ...
Business Wire
11/29/2022 Bridgewater Associates LP Has $859,000 Holdings in Invitae Co. (NYSE:NVTA) - Ticker Report
Bridgewater Associates LP lifted its holdings in Invitae Co. ( NYSE:NVTA ‚Ai Get Rating ) by 17.1% during the 2nd quarter, Holdings Channel reports. The fund owned 352,058 shares of the medical research company's stock after acquiring an additional 51,314 shares during the quarter. Bridgewater Associates LP's holdings in ...
Ticker Report
11/29/2022 Bridgewater Associates LP Has $859,000 Stock Position in Invitae Co. (NYSE:NVTA) - Watch List News
Bridgewater Associates LP boosted its position in shares of Invitae Co. ( NYSE:NVTA ‚Ai Get Rating ) by 17.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 352,058 shares of the medical research company's stock after ...
watchlistnews.com
11/27/2022 Not all genetic tests are created equal | by Invitae | Health decoded: The science of healthy living
Originally published on Invitae.com on December 17, 2018 Genetic tests that are not comprehensive may provide a false sense of confidence or risk for patients wanting to understand their potential for developing heritable breast cancer. Genetic testing was originally available only to medical specialists and genetic counselors for the purpose ...
Medium
11/26/2022 Axxcess Wealth Management LLC Grows Position in Invitae Co. (NYSE:NVTA)
Axxcess Wealth Management LLC grew its stake in shares of Invitae Co. ( NYSE:NVTA ‚Ai Get Rating ) by 14.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 50,252 shares of the medical research company's stock after buying an ...
Ticker Report
11/25/2022 Invitae (NYSE:NVTA) Shares Up 7.8%
Invitae Co. ( NYSE:NVTA ‚Ai Get Rating )'s stock price shot up 7.8% during trading on Wednesday . The stock traded as high as $2.78 and last traded at $2.77. 23,439 shares traded hands during trading, a decline of 100% from the average session volume of 11,116,942 shares. The stock had ...
American Banking News
11/25/2022 Invitae (NYSE:NVTA) Trading 7.8% Higher
Invitae Co. (NYSE:NVTA ‚Ai Get Rating)'s share price traded up 7.8% on Wednesday . The company traded as high as $2.78 and last traded at $2.77. 23,439 shares changed hands during trading, a decline of 100% from the average session volume of 11,116,942 shares. The stock had previously closed ...
zolmax.com
11/25/2022 Do you still think Invitae Corporation (NYSE:NVTA) is worth a look?
In yesterday's Wall Street session, Invitae Corporation (NYSE:NVTA) shares traded at $2.82, up 9.73% from the previous session. As of this writing, 11 analysts cover Invitae Corporation (NYSE:NVTA). The consensus rating among analysts is ‚AoUnderweight‚Ao. NVTA stock price is now 8.01% away from the 50-day ...
fostersresearch.com
11/24/2022 Ocular Genetic Diagnostic Market Research Methodology and Outlook Trends 2022 To 2030 | Quest Diagnostics, Columbia ophthalmology, Centogene, DBGen
... mode=V087 The Key companies profiled in the Ocular Genetic Diagnostic Market: Quest Diagnostics, Columbia ophthalmology, Centogene, DBGen, Medgenome, Sankara Nethralaya, Fulgent Genetics, GeneDx, Devyser, Invitae Corporation Ocular Genetic Diagnostic Market segment by Type: Next-generation Sequencing (NGS) Multiplex Ligation-Dependent Probe Amplification (MLPA) Fragment Analysis PCR for Repeat Expansion ...
heraldkeeper.com
11/24/2022 Invitae (NYSE:NVTA) Shares Down 5.5%
Invitae Co. ( NYSE:NVTA ‚Ai Get Rating )'s stock price traded down 5.5% on Tuesday . The company traded as low as $2.58 and last traded at $2.59. 78,854 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 11,203,762 shares. The stock had ...
zolmax.com
11/24/2022 Invitae (NYSE:NVTA) Stock Price Down 5.5%
Shares of Invitae Co. (NYSE:NVTA ‚Ai Get Rating) fell 5.5% on Tuesday . The stock traded as low as $2.58 and last traded at $2.59. 78,854 shares changed hands during trading, a decline of 99% from the average session volume of 11,203,762 shares. The stock had previously closed at $2.74 ...
baseballnewssource.com
11/24/2022 Invitae Corporation [NVTA] fell -83.17% so far this year. What now?
Industry Invitae Corporation [NVTA] fell -83.17% so far this year. What now? By Misty Lee - November 23, 2022 Facebook Twitter Pinterest Invitae Corporation [NYSE: NVTA] plunged by -$0.17 during the normal trading session on Tuesday and reaching a high of $2.77 during the day while it closed the day at ...
dbtnews.com
11/23/2022 Cibc World Market Inc. Raises Stock Position in Invitae Co. (NYSE:NVTA)
Cibc World Market Inc. lifted its stake in shares of Invitae Co. (NYSE:NVTA ‚Ai Get Rating) by 249.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 187,571 shares of the medical research company's stock after ...
etfdailynews.com
11/23/2022 Invitae Corporation (NVTA): Get Prepared for Trading Lift Off
Let's start up with the current stock price of Invitae Corporation (NVTA), which is $2.57 to be very precise. The Stock rose vividly during the last session to $2.77 after opening rate of $2.77 while the lowest price it went was recorded $2.53 before closing at $2.74.Recently in ...
investchronicle.com
11/22/2022 StockNews.com Upgrades Invitae (NYSE:NVTA) to “Sell”
StockNews.com upgraded shares of Invitae ( NYSE:NVTA ‚Ai Get Rating ) to a sell rating in a research note published on Friday morning. A number of other analysts have also recently weighed in on the stock. JPMorgan Chase & Co. cut shares of Invitae from a neutral rating to an underweight rating ...
Ticker Report